Phase I/IIa Study of Pharmacokinetics and Safety of Atorvastatin in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

Trial Profile

Phase I/IIa Study of Pharmacokinetics and Safety of Atorvastatin in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 25 Feb 2013

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atherosclerosis; Coronary artery disease
  • Focus Adverse reactions; Biomarker; Pharmacodynamics
  • Most Recent Events

    • 25 Feb 2013 Additional lead trial centres added as reported by ClinicalTrials.gov record.
    • 16 Nov 2012 Planned number of patients changed from 24 to 32 as reported by ClinicalTrials.gov.
    • 16 Nov 2012 Planned End Date changed from 1 Jul 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top